These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Botulinum toxin type A in the treatment plan for cerebral palsy]. Strobl W Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050 [TBL] [Abstract][Full Text] [Related]
4. [Cerebral palsy therapy]. Papazian O; Alfonso I Rev Neurol; 1997 May; 25(141):728-39. PubMed ID: 9206600 [TBL] [Abstract][Full Text] [Related]
6. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A. Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411 [TBL] [Abstract][Full Text] [Related]
7. Assessment and treatment of movement disorders in children with cerebral palsy. Deon LL; Gaebler-Spira D Orthop Clin North Am; 2010 Oct; 41(4):507-17. PubMed ID: 20868881 [TBL] [Abstract][Full Text] [Related]
8. Acute deep-brain stimulation of the internal and external globus pallidus in primary dystonia: functional mapping of the pallidum. Houeto JL; Yelnik J; Bardinet E; Vercueil L; Krystkowiak P; Mesnage V; Lagrange C; Dormont D; Le Bas JF; Pruvo JP; Tezenas du Moncel S; Pollak P; Agid Y; Destée A; Vidailhet M; Arch Neurol; 2007 Sep; 64(9):1281-6. PubMed ID: 17846266 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity. Dai AI; Wasay M; Awan S J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853 [TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
11. Restoring balance in focal limb dystonia with botulinum toxin. Sheean G Disabil Rehabil; 2007 Dec; 29(23):1778-88. PubMed ID: 18033603 [TBL] [Abstract][Full Text] [Related]
12. [Medical aspects of the medical treatment in dystonia]. Grabli D; Vidailhet M Bull Acad Natl Med; 2011; 195(4-5):935-50. PubMed ID: 22375361 [TBL] [Abstract][Full Text] [Related]
13. Status dystonicus and Hallervorden-Spatz disease: treatment with intrathecal baclofen and pallidotomy. Kyriagis M; Grattan-Smith P; Scheinberg A; Teo C; Nakaji N; Waugh M J Paediatr Child Health; 2004; 40(5-6):322-5. PubMed ID: 15151592 [TBL] [Abstract][Full Text] [Related]
14. [The study and treatment of dystonias in childhood]. Pascual-Pascual SI Rev Neurol; 2006 Oct; 43 Suppl 1():S161-8. PubMed ID: 17061184 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of movement disorders with deep brain stimulation]. Toft M; Lilleeng B; Ramm-Pettersen J; Røste GK; Pedersen L; Skogseid IM; Dietrichs E Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1972-6. PubMed ID: 18787575 [TBL] [Abstract][Full Text] [Related]
16. Long-term effects of pallidal deep brain stimulation in tardive dystonia. Gruber D; Trottenberg T; Kivi A; Schoenecker T; Kopp UA; Hoffmann KT; Schneider GH; Kühn AA; Kupsch A Neurology; 2009 Jul; 73(1):53-8. PubMed ID: 19564584 [TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy. Kaishou Xu ; Tiebin Yan ; Jianning Mai Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892 [TBL] [Abstract][Full Text] [Related]